Cullinan Oncology LLC (CGEM)
Healthcare
Biotechnology
16.50 $
-5.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Cullinan Oncology LLC (CGEM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -46 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31 | -34 | -18 | -38 | -36 | -34 | -37 | -43 | -58 | -37 | -38 | -46 | -179 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | |
| 7.9 | 7.7 | 7.5 | 8.2 | 11 | 9.4 | 9.6 | 9.4 | 9.9 | 9.5 | 7.3 | 7.6 | 34 | |
| 7.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.6 | -0.2 | 3.3 | -5.9 | -1.1 | 1.8 | 4.8 | -1.8 | 4.2 | 5.5 | 6.1 | -3.3 | 13 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 37 | 0.0 | 0.0 | 37 | |
| 12 | -43 | 51 | 13 | -185 | 20 | 16 | 37 | 53 | 67 | 22 | 32 | 176 | |
| 38 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 39 | 0.1 | 0.2 | 1.1 | 262 | 1.3 | 1.6 | 0.0 | 0.4 | 0.0 | 0.7 | 0.4 | 1.5 | |
| 20 | -77 | 34 | -24 | 41 | -13 | -19 | -6.4 | -3.8 | 31 | -15 | -13 | -1.6 | |
| -31 | -34 | -18 | -38 | -36 | -34 | -37 | -43 | -58 | -37 | -38 | -46 | -179 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.